Defining the genomic architecture of Age-related Macular Degeneration (AMD) to improve diagnosis, treatment, and prevention.
AMD is the most common cause of severe vision loss
among the elderly.
The condition is strongly influenced by genomic variation.
For more than 20 years, the IAMDGC and its individual members have advanced understanding of the genomics of AMD. Learn more about our resources and datasets here.
Our research has informed genetic testing capabilities
that are useful in diagnosis and treatment.